InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Shukla Sath, Chief Financial Officer. Officer active across 1 companies, notably Spero Therapeutics, Inc.. Aggregated, 4 filings have been logged. The latest transaction was filed on 1 February 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
038,014 shares0
Common Stock
SEC:0000899243-22-004593·
038,014 shares0
Common Stock
SEC:0000899243-22-004593:0·
024,067 shares0
Common Stock
SEC:0000899243-21-034498·
024,067 shares0
Common Stock
SEC:0000899243-21-034498:0·
4 of 4 declarations
About Shukla Sath
Sath Shukla is the Chief Financial Officer of Spero Therapeutics, Inc., a biopharmaceutical company focused on developing innovative treatments. In his role, he oversees financial operations and contributes to the company's growth strategy. Sath Shukla plays a crucial role in managing financial resources and optimizing Spero's economic performance.
